| Host&Organizing Committees | President | Kyung-Chul Choi (Chungbuk National University) |
|---|---|---|
| Vice-President | Keon-Wook Kang (Seoul National University) | |
| Secretary General | Ki Taek Nam (Yonsei University) | |
| Scientific Committee | Chair | Donghak Kim (Konkuk University) Jeong-Hwan Che (Seoul National University Hospital) |
| General Management Committee | Chair | Kyu-Bong Kim (Dankook University) |
| Finance Committee | Chair | Jongsun Park (Chungnam National University) |
| International Relationship Committee | Chair | Minsoo Noh (Seoul National University) |
| Educational Committee | Chair | Kyung-Min Lim (Ewha Womans University) Jun-Won Yun (Seoul National University) |
| Program Planning Committee | Chair | Bumseok Kim (Chonbuk National University) |
| Public Relations and Communication Committee | Chair | Joo Young Lee (The Catholic University of Korea) |
| Membership Committee | Chair | Soon-Mi Shim (Sejong University) |
| Fundraising Committee | Chair | Ki-Suk Kim (Korea Institute of Toxicology) |
| Toxicology Database Committee | Chair | Ok-Nam Bae (Hanyang University) |
| Risk Communication Advisory Committee | Chair | Kyuhong Lee (Korea Institute of Toxicology) |
| Young Scientist Committee | Chair | Jeong-Yun Choi (Sungkyunkwan University) |
| May 15 (Thursday), 2025 | ||
|---|---|---|
| 12:30 |
등록 |
|
| 13:20-13:30 |
개회사 사회 : 윤준원 교수 (서울대학교) |
|
| 최경철 회장 (한국독성학회) | ||
| 13:30-15:30 |
Part 1 : 장기 칩, 오가노이드 기반 독성평가법 개발 좌장 : 이병철 교수 (숙명여자대학교) |
|
|
13:30-14:00 미세생리시스템 및 오가노이드를 이용한 독성평가의 임상연계 조영재 교수 (분당서울대학교병원) 14:00-14:30 면역활성 종양 구상체 기반 신약 개발 최근 기법 서행란 책임연구원 (한국파스퇴르연구소) 14:30-15:00 의약품 독성/유효성 검증을 위한 미세생리시스템과 이를 활용한 AI 예측 기술 박승 교수 (충북대학교) 15:00-15:30 장기칩을 활용한 첨단의약품의 안전성평가 및 최신 독성평가기법 개발 안중호 교수 (성균관대학교) |
||
| 15:30-16:00 | Break | |
| 16:00-18:00 |
Part 2 : 첨단의약품 안전성평가 좌장 : 양세란 교수 (강원대학교) |
|
|
16:00-16:30 RNA 치료제의 최신 동향 김연준 대표 (㈜큐마인) 16:30-17:00 첨단바이오의약품 및 첨단의약품 비임상평가 사례분석 김종원 박사 (K-헬스미래추진단) 17:00-17:30 염증성 장질환에서 프로바이오틱스의 활용: Nod2 매개 신호기전 연구 박종환 교수 (전남대학교) 17:30-18:00 스텔스바디 항체원천기술에 의해 안전성 및 유효성이 개선된 차세대 ADC 개발 장기환 연구소장 (㈜크로스포인트 테라퓨틱스) |
||
| 18:00-18:10 | 총평 및 폐회사 | |
| May 16 (Friday), 2025 | ||
|---|---|---|
| 08:30 | Registration | |
| 09:30-09:50 |
Welcome Remarks Kyung-Chul Choi (President of KSOT, Chungbuk National University) Seogyoun Kang (Director General, National Institute of Food and Drug Safety Evaluation) Jeong-Doo Heo (President of Korea Institute of Toxicology) Eui-Kyung Lee (President of KFDC, Sungkyunkwan University) |
|
| 09:50-10:30 |
Plenary Lecture I (Online Zoom) Chairperson: Ji-Eun Kim (The Catholic University of Korea) |
|
|
The Evolving Benefit vs. Risk Value Proposition for GLP-1 Medicines Daniel Drucker (Mt. Sinai Hospital, University of Toronto, Canada) |
||
| 10:30-10:40 | Break | |
| 10:40-12:20 |
Session 1 Toxicological Implications of Glucagon-Like Peptide-1 (GLP-1) in Metabolic Regulation and Therapeutic Applications Chairperson: Jeong-Hwan Che (Seoul National University Hospital) |
|
|
10:40-11:05 Beyond Weight Loss: Potential Neural Mechanisms for Toxicological Negative Emotions Linked to GLP-1 Therapies Hyung Jin Choi (Seoul National University) 11:05-11:30 Adipose Tissue Lipid Metabolism: Exploring Toxicological Aspects in Therapeutic Targeting Yun-Hee Lee (Seoul National University) 11:30-11:55 Therapeutic Targeting of PAK4 in Metabolic Disease and Its Toxicological Implication Eun Ju Bae (Jeonbuk National University) 11:55-12:20 Special Lecture Non-Canonical Insulin Signaling via BRD7: A Targetable Pathway for Metabolic Disease Prevention Sang Won Park (Harvard Medical School, Boston Children's Hospital, USA) |
||
| 12:30-13:30 | Council Meeting / Lunch | |
| 13:30-14:10 |
Plenary Lecture II Chairperson: Mi-Kyoung Kwak (The Catholic University of Korea) |
|
|
Abnormal Lipid Metabolism and Fatty Liver Disease: A Comprehensive Review of My Toxicology Research Byung-Hoon Lee (Seoul National University) |
||
| 14:10-15:40 |
Session 2 Experimental Determination of Ultrafine Dusts on the Respiratory Organs and Secondary Organs Chairperson: Eun-Jung Park (Kyung Hee University) |
|
|
14:10-14:40 PM2.5 and Human Health: Toxicity Studies on Respiratory, Brain, Kidney, and Vascular Systems and the Korean Integrated Research Framework Kyuhong Lee (Korea Institute of Toxicology) 14:40-15:10 Studies on the Pathological Effect of PM2.5 on the Brain Using Inhalation and Intra-tracheal Instillation Exposure Model Do Geun Kim (Korea Brain Research Institute) 15:10-15:40 Adverse Outcomes, Biokinetics, and Key Mechanisms of Respiratory Toxicity of Exhuast and Non-exhaust Ultrafine Particles Wan-Seob Cho (Dong-A University) |
||
| 15:40-16:00 | Break | |
| 16:00-17:30 (Sponsored by KIT) |
Session 3 Current Trends in Cardiotoxicity Assessment of Drugs: CiPA Chairperson: Sujeong Park (National Institute of Food and Drug Safety Evaluation) |
|
|
16:00-16:30 Multi-Ion Channel Assay in Cardiovascular Safety Pharmacology Woo Kyung Kim (Dongguk University) 16:30-17:00 In Silico Cardiac Pharmacological Safety Assessment Methods and Introduction to Application Software Ki Moo Lim (Kumoh National Institute of Technology) 17:00-17:30 Advanced Cardiac Pharmacological Safety Based on Human iPS C-Yoon Kim (Konkuk University) |
||
| 17:30-17:50 | Closing Remarks | |
| 17:50 | Reception | |
Date : May 15 (Thu) ~ 16 (Fri), 2025
Venue : New Millennium Hall, Konkuk University, Seoul, Korea
Title : Next-Generation Disease Prevention: Insights from Future Toxicology Technologies